IRFAN ALI: Open Payments
NPI 1235153719 · GERMANTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$645 in 35 payments from 10 companies in 2025. Trend: 2023 $832 · 2024 $993 · 2025 $645
Food & beverage: $645
| Company | Payments | Amount |
|---|---|---|
| Tris Pharma Inc | 13 | $167 |
| ABBVIE INC. | 7 | $155 |
| Otsuka America Pharmaceutical, Inc. | 4 | $75 |
| Corium, LLC | 3 | $56 |
| Supernus Pharmaceuticals, Inc. | 2 | $50 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| Lundbeck LLC | 1 | $34 |
| E.R. Squibb & Sons, L.L.C. | 1 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: Dyanavel XR, VRAYLAR, REXULTI, Azstarys, Qelbree, Auvelity, COBENFY, FANAPT.
Industry payments across TN — which companies pay providers there.
